Research Progress of Biomakers Proteomics-based in Lung Cancer

Proteomic technologies can be applied to cancer research to detect differential protein expression that could find cancer biomakers. Lung cancer biomarker discovery is significant due to its anticipated critical role in early diagnosis, therapy guidance, and prognosis monitoring of lung cancer. Ther...

Full description

Bibliographic Details
Main Authors: Hui XIE, Zhengang CHEN, Guangshun WANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2015-06-01
Series:Chinese Journal of Lung Cancer
Subjects:
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2015.06.11
_version_ 1819088064065044480
author Hui XIE
Zhengang CHEN
Guangshun WANG
author_facet Hui XIE
Zhengang CHEN
Guangshun WANG
author_sort Hui XIE
collection DOAJ
description Proteomic technologies can be applied to cancer research to detect differential protein expression that could find cancer biomakers. Lung cancer biomarker discovery is significant due to its anticipated critical role in early diagnosis, therapy guidance, and prognosis monitoring of lung cancer. Therefore, there is an indeed need to identify new biomarkers for early diagnosis and prognosis that could serve to open novel therapeutic means. This article briefly introduces the latest reports in proteomic studies of lung cancer. It contains diagnostic, prognostic, and predictive biomarkers, and a summary based on the most recent literature and our own work.
first_indexed 2024-12-21T21:46:05Z
format Article
id doaj.art-7e8088cd506e4aaaadb1808a85f912e3
institution Directory Open Access Journal
issn 1009-3419
1999-6187
language zho
last_indexed 2024-12-21T21:46:05Z
publishDate 2015-06-01
publisher Chinese Anti-Cancer Association; Chinese Antituberculosis Association
record_format Article
series Chinese Journal of Lung Cancer
spelling doaj.art-7e8088cd506e4aaaadb1808a85f912e32022-12-21T18:49:13ZzhoChinese Anti-Cancer Association; Chinese Antituberculosis AssociationChinese Journal of Lung Cancer1009-34191999-61872015-06-0118639139610.3779/j.issn.1009-3419.2015.06.11Research Progress of Biomakers Proteomics-based in Lung CancerHui XIE0Zhengang CHEN1Guangshun WANG2Baodi Clinical Hospital, Tianjin Medical University, Tianjin 301800, ChinaBaodi Clinical Hospital, Tianjin Medical University, Tianjin 301800, ChinaBaodi Clinical Hospital, Tianjin Medical University, Tianjin 301800, ChinaProteomic technologies can be applied to cancer research to detect differential protein expression that could find cancer biomakers. Lung cancer biomarker discovery is significant due to its anticipated critical role in early diagnosis, therapy guidance, and prognosis monitoring of lung cancer. Therefore, there is an indeed need to identify new biomarkers for early diagnosis and prognosis that could serve to open novel therapeutic means. This article briefly introduces the latest reports in proteomic studies of lung cancer. It contains diagnostic, prognostic, and predictive biomarkers, and a summary based on the most recent literature and our own work.http://dx.doi.org/10.3779/j.issn.1009-3419.2015.06.11Lung neoplasmaProteomicsBiomarker
spellingShingle Hui XIE
Zhengang CHEN
Guangshun WANG
Research Progress of Biomakers Proteomics-based in Lung Cancer
Chinese Journal of Lung Cancer
Lung neoplasma
Proteomics
Biomarker
title Research Progress of Biomakers Proteomics-based in Lung Cancer
title_full Research Progress of Biomakers Proteomics-based in Lung Cancer
title_fullStr Research Progress of Biomakers Proteomics-based in Lung Cancer
title_full_unstemmed Research Progress of Biomakers Proteomics-based in Lung Cancer
title_short Research Progress of Biomakers Proteomics-based in Lung Cancer
title_sort research progress of biomakers proteomics based in lung cancer
topic Lung neoplasma
Proteomics
Biomarker
url http://dx.doi.org/10.3779/j.issn.1009-3419.2015.06.11
work_keys_str_mv AT huixie researchprogressofbiomakersproteomicsbasedinlungcancer
AT zhengangchen researchprogressofbiomakersproteomicsbasedinlungcancer
AT guangshunwang researchprogressofbiomakersproteomicsbasedinlungcancer